Journal of Pain Research (Jul 2023)

Painful Diabetic Peripheral Neuropathy – A Survey of Patient Experiences

  • Abd-Elsayed AA,
  • Marcondes LP,
  • Loris ZB,
  • Reilly D

Journal volume & issue
Vol. Volume 16
pp. 2269 – 2285

Abstract

Read online

Alaa A Abd-Elsayed,1 Lizandra P Marcondes,2 Zachary B Loris,2 Daniel Reilly3 1University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; 2Averitas Pharma (A Grünenthal Company), Morristown, NJ, USA; 3SMS Research Advisors, Minneapolis, MN, USACorrespondence: Lizandra P Marcondes, Averitas Pharma (A Grünenthal Company), 360 Mount Kemble Avenue, Morristown, NJ, 07960, USA, Tel +1 908-393-0024, Fax +1 908-306-1631, Email [email protected]: An online survey was conducted in the USA to obtain information about the knowledge and experiences of patients with painful diabetic peripheral neuropathy (pDPN).Patients and Methods: 506 adults with diabetes and pDPN affecting the feet for ≥ 6 months, for which pain medication had been prescribed for ≥ 6 months, completed an online survey questionnaire in March 2021.Results: 79% of respondents had type 2 diabetes, 60% were male, 82% were Caucasian and 87% had comorbidities. Pain was significant to severe in 49% of respondents, and 66% had disability due to nerve pain. Anticonvulsants, over-the-counter pills and supplements were the most commonly used medications. Topical creams/patches were prescribed in 23% of respondents. 70% had tried multiple medications for their pain. 61% of respondents had to see ≥ 2 doctors before receiving a correct diagnosis of pDPN. 85% of respondents felt that the doctor understood their pain and its impact on their life. 70% had no difficulty finding the information they wanted. 34% felt insufficiently informed about their condition. A medical professional was the primary, and most trusted, source of information. Frustration, worry, anxiety and uncertainty were the most commonly reported emotions. Respondents were generally eager to find new medications for pain relief and desperate for a cure. Lifestyle changes because of nerve pain were most commonly associated with physical disabilities and sleep disturbance. Better treatments and freedom from pain were the overriding perspectives when considering the future.Conclusion: Patients with pDPN are generally well informed about their pain and trust their doctor but remain unsatisfied with their current treatment and struggle to find a lasting solution for their pain. Early identification and diagnosis of pain in diabetics, and education about treatments, is important to minimize the impact of pain on quality of life and emotional well-being.Keywords: painful diabetic peripheral neuropathy, nerve pain, foot pain, online survey

Keywords